SEER Inquiry System - Question 20041053 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 07/23/2025 1:01 PM

Question 20041053

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

#1: CS Manual, Part II, 465. Vers 1.0, Jan. 1, 2004

#2: 2004 SEER Manual, C-484

Question:

CS Site Specific Factor 6--Breast: Can we interpret the in situ component as "minimal" when the pathology report states "1.1 cm infiltrating duct carcinoma and no extensive intraductal component"?

Discussion:

Answer:

This answer was provided in the context of CSv1 coding guidelines. The response may not be used after your registry database has been converted to CSv2.

Yes. Based on the information provided above, the in situ component is "mininmal" for the purpose of coding Breast CS Site Specific Factor 6. The phrase "no extensive intraductal component" suggests that there is some intraductal carcinoma present.

Cancer Site Category:

Breast

Data Item Category:

N/A

Other Category:

N/A

Year:

2004